RankingsPricing
  1. US-listed companies
  2. MEDICINOVA INC
  3. Financials
  4. EBITDA

MEDICINOVA INCMNOV

Market cap
$72.59M
P/E ratio
SummaryFinancials
Period EndEBITDA (Million USD)YoY (%)
Dec 31, 2024-13+28.08%
Dec 31, 2023-10-32.38%
Dec 31, 2022-15+43.39%
Dec 31, 2021-10-28.02%
Dec 31, 2020-14+1.07%
Dec 31, 2019-14-9.99%
Dec 31, 2018-16+19.71%
Dec 31, 2017-13+19.61%
Dec 31, 2016-11+23.56%
Dec 31, 2015-9-4.22%
Dec 31, 2014-9+134.25%
Dec 31, 2013-4-56.11%
Dec 31, 2012-9-36.94%
Dec 31, 2011-14

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)